ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

DAVID SWETT MD

1800 MORMON MILL RD BLDG B#2 AUSTIN HEART MARBLE FALLS

Marble falls | Texas | 78654

(830) 798-2082

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,073Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 1019

$488K Total Retail Price of All Prescriptions

Rank: 110 out of 1019

817 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 8,592 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
METOPROLOL SUCCINATE 704 645 1 1
SIMVASTATIN 648 609 2 5
LISINOPRIL 610 558 3 2
AMLODIPINE BESYLATE 578 557 4 4
CARVEDILOL 526 483 5 3
PRAVASTATIN SODIUM 344 324 6 16
METOPROLOL TARTRATE 342 330 7 8
CRESTOR 285 282 8 13
WARFARIN SODIUM 271 245 9 9
FUROSEMIDE 265 255 10 6
ISOSORBIDE MONONITRATE ER 230 223 11 12
ATORVASTATIN CALCIUM 229 217 12 10
SPIRONOLACTONE 217 211 13 23
DIGOXIN 201 197 14 14
LOSARTAN POTASSIUM 189 189 15 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 178 155 16 28
HYDROCHLOROTHIAZIDE 176 169 17 18
PRADAXA 140 140 18 24
FENOFIBRATE 137 131 19 58
TRICOR 124 124 20 61
POTASSIUM CHLORIDE 122 117 21 15
ZETIA 114 93 22 30
VERAPAMIL ER 113 109 23 77
DIOVAN 101 97 24 20
SOTALOL 96 92 25 35
DIOVAN HCT 88 77 26 39
TRIAMTERENE-HCTZ 85 82 27 57
CLOPIDOGREL 83 74 28 7
PLAVIX 83 79 28 11
FLECAINIDE ACETATE 70 69 30 51
ATENOLOL 65 65 31 19
AMLODIPINE BESYLATE-BENAZEPRIL 63 63 32 47
NIASPAN 60 58 33 33
NITROSTAT 58 54 34 27
LOSARTAN-HYDROCHLOROTHIAZIDE 54 52 35 31
RAMIPRIL 54 54 35 21
LOVASTATIN 53 53 37 44
BENAZEPRIL HCL 53 53 37 69
JANTOVEN 53 53 37 73
VYTORIN 51 39 40 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.